12 results
PRE 14A
RVNC
Revance Therapeutics Inc
12 Mar 21
Preliminary proxy
4:13pm
to time, on the committee’s view of the quality, expertise recruitment and retention of sales and marketing personnel in our commercial organization
10-K
0c9tbx3
28 Mar 14
Annual report
12:00am
424B4
z98x70 gte2j6jairhn
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
ztk w46tpl6x9dx5
31 Dec 13
IPO registration
12:00am
DRS
9746rju2wqbn82ztm5
19 Apr 13
Draft registration statement
12:00am
- Prev
- 1
- Next